Viewing Study NCT00463203


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-25 @ 5:04 PM
Study NCT ID: NCT00463203
Status: COMPLETED
Last Update Posted: 2011-06-29
First Post: 2007-04-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
Sponsor: Rigshospitalet, Denmark
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module